LB Pharmaceuticals

tenant

drug

t-VNS verum

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

DEVICE

Pre-approval / investigational in the US

Developed by cerbomed GmbH

1 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

DEVICE

Indications

Investigational (via trials)

Schizophrenia Schizophrenia, Disorganized Mental Disorders Schizophrenia Schizophrenia, Catatonic Illusions Tardive Dyskinesia Hallucinations Delusions Psychotic Disorders Dementia Neuroleptic Malignant Syndrome Schizophrenia, Paranoid

Trials

1

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

NCT01176721Phase 2Completed

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

company

trial

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

PHASE2

trial

indication

indication

Schizophrenia, Disorganized

indication

Mental Disorders

indication

indication